聰耳2號(hào)方治療腎虛血瘀型突發(fā)性耳聾的臨床研究.pdf

1、新疆醫(yī)科大學(xué)碩士學(xué)位論文聰耳2號(hào)方治療腎虛血瘀型突發(fā)性耳聾的臨床研究姓名：鄒廣華申請(qǐng)學(xué)位級(jí)別：碩士專業(yè)：中西醫(yī)結(jié)合臨床指導(dǎo)教師：@200904新疆醫(yī)科大學(xué)醫(yī)學(xué)碩士學(xué)位論文新疆醫(yī)科大學(xué)醫(yī)學(xué)碩士學(xué)位論文—2—ClinicalstudyofCongererhaofangonsuddensensineuralhearingloss（kidneydeficiencyofbloodstasis）Postgraduate:ZouGuanghuaSup

2、ervis:Pro.LiYanhuaAbstractObjective:TostudytheeffectofCongererhaofanginthetreatmentofsuddensensineuralhearingloss（kidneydeficiencybloodstasis）oftheclinicalefficacyadversereactions；toobjectiveevaluationofitstreatmentofsud

3、densensineuralhearingloss（kidneydeficiencybloodstasis）effectivenesssafetytoexpleareliablesafehighlytreatmentusingTraditionalChineseMedicineonsuddensensineuralhearingloss（kidneydeficiencybloodstasis）.Methods:95suddensensi

4、neuralhearingloss（kidneydeficiencybloodstasis）patientswereromlydividedintotwogroups49casesastreatmentgroupinwhichabasictreatmentcombinedwithCongererhaofang46casesascontrolgroupwithabasictreatment.Twoweeksfonecourseoftrea

5、tment.Observedthechangeofpuretonehearingthresholdmeasuredtinnitushicapinventyplasmacalcitoningenerelatedpeptidebefetwoweeksafterthetreatment.Results:Aftertwoweekstreatment，thetwogroupsimprovethelevelofhearing（89.80%inthe

6、treatmentgroup76.09%inthecontrolgroup）thetwogroupshavesignificantdifferences(P0.05).TherearesignificantdifferencesinCongererhaofangimprovingthetinnitushicapinventythelevelofplasmacalcitoningenerelatedpeptidecomparedwitht

7、hecontrolgroup(P0.05).Thedifferenceofgeneralinfmationoftwogroupsarenotsignificantbefetreatment(P＞0.05).Conclusions:Congererhaofangcannotonlyimprovethelevelofhearingofsuddensensineuralhearingloss（kidneydeficiencybloodstas

8、is）patients，butasloevidentlyalleviatethesymptomsoftinnitusincreasethelevelofplasmacalcitoningenerelatedpeptidethereby，Congererhaofanghassignificantclinicalefficacyonsuddensensineuralhearingloss（kidneydeficiencybloodstasi